Sponsor Directory

Duke University clinical trials

Sponsor pages show live ClinicalTrials.gov search results and objective aggregate stats only. They do not describe sponsor quality, reputation, or expected outcomes.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

2718

Shown on this page

Current sort

Live official records

Open in full search

Conditions: Autism, Autism Spectrum Disorder
Interventions: Cord Tissue Mesenchymal Stromal Cells, Placebo Infusion; Biological · Other
Lead sponsor: Joanne Kurtzberg, MD; Other
Eligibility: 4 Years to 11 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer
Interventions: Trastuzumab, Trastuzumab Emtansine (T-DM1), Pertuzumab, Tucatinib; Drug
Lead sponsor: Carey Anders, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 8
States / cities: San Francisco, California • Boston, Massachusetts • Ann Arbor, Michigan + 5 more

Conditions: Sickle Cell Disease, Sickle Cell Anemia
Interventions: Chart Review, Survey; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Neurological Disorder, Autoimmune Diseases
Interventions: Mycophenolate Mofetil, Azathioprine; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 17
States / cities: Palo Alto, California • Miami, Florida • Chicago, Illinois + 12 more

Conditions: Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma
Interventions: PEP-CMV; Drug
Lead sponsor: Daniel Landi; Other
Eligibility: 3 Years to 35 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke, Mental Health Wellness 1
Interventions: modified Cognitive Behavioral Therapy (mCBT), Occupational or Speech Therapy; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Breast Cancer, Triple Negative Breast Cancer
Interventions: Niraparib, Dostarlimab, Radiation therapy; Drug · Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Boston, Massachusetts • Durham, North Carolina + 1 more

Conditions: Acute Respiratory Distress Syndrome
Interventions: Inhaled Carbon Monoxide at 200 ppm, Inhaled Medical air; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 7
States / cities: Boston, Massachusetts • St Louis, Missouri • Brooklyn, New York + 2 more

Conditions: Spontaneous Intracranial Hypotension
Interventions: photon counting detector CT myelography (PCD- CTM), energy integrating detector CT myelography (EID-CTM); Diagnostic Test
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Healthy
Interventions: Ozone, Filtered Air; Drug · Other
Lead sponsor: Robert Tighe, MD; Other
Eligibility: 18 Years to 35 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Retinitis Pigmentosa
Interventions: N-acetylcysteine, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 485 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 24
States / cities: Davis, California • Los Angeles, California • San Francisco, California + 21 more

Conditions: Environmental and Genetic Factors on Lung Function
Interventions: Ozone, Filtered Air; Drug · Other
Lead sponsor: Robert Tighe, MD; Other
Eligibility: 18 Years to 45 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

About this Duke University sponsor directory page

What this page lists: U.S. ClinicalTrials.gov public records where Duke University is the lead sponsor, including recruiting, not yet recruiting, and active not recruiting trials across phase 1, phase 2, and phase 3.
How to narrow results: Use the filters above to scope by condition, intervention, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, age, or NCT ID within Duke University trials.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, sponsor quality scoring, ranking of trials, or AI-generated medical summaries.

Duke University clinical trials

Filter and sort this sponsor

Live official records

hCT-MSC in Children With Autism Spectrum Disorder

Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Disease-Modifying Treatments for Myasthenia Gravis

PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma

Emotional Recovery Post-Stroke

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

CVFs in SIH: EID vs. PCD CTM

Mechanisms of Ozone-Induced Alterations in Efferocytosis and Phagocytosis

Oral N-acetylcysteine for Retinitis Pigmentosa

ONES Grant: CXCL10/CXCR3 Regulation of Ozone-Induced Epithelial Permeability

About this Duke University sponsor directory page